NCT04387097View on ClinicalTrials.gov

Drip-infusion of Remifentanil for RIH

CompletedOBSERVATIONAL
Enrollment

559

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

July 22, 2019

Conditions
Hyperalgesia
Interventions
DRUG

remifentanil

postoperative drip-infusion of remifentanil

Trial Locations (1)

11490

TriService General Hospital, Taipei

All Listed Sponsors
lead

Tri-Service General Hospital

OTHER

NCT04387097 - Drip-infusion of Remifentanil for RIH | Biotech Hunter | Biotech Hunter